Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Cantor Fitzgerald says 15% of biotech companies down 40% or more
-
Capricor Therapeutics to Present at Upcoming Investor and Scientific Conferences
-
Capricor Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Capricor Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Capricor Therapeutics to Present at Upcoming Investor Conferences
-
Capricor Therapeutics (CAPR) Announces 4.94M Share Offering at $4.66/sh
-
Capricor Therapeutics Announces $23 Million Registered Direct Offering
-
Capricor Therapeutics to Present at Upcoming Investor Conferences
-
Capricor Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
Capricor Therapeutics to Participate in the Cantor Fitzgerald Rare Orphan Disease Summit
-
Capricor Therapeutics to Present at the Upcoming Investor and Industry Healthcare Conferences
